Clinical Perspectives

FDA-approved Pembrolizumab for Treatment of Metastatic Chemo Refractory Endometrial Carcinoma

Dr. Monica Avila co-authored “Exceptional Response to Pembrolizumab for Treatment of Metastatic Chemo Refractory Endometrial Carcinoma in a Patient...

Chimeric RNAs Reveal Putative Neoantigen Peptides for Developing Tumor Vaccines for Breast Cancer

Dr. Brian Czerniecki, chair of the Breast Oncology Program, co-authored the publication, “Chimeric RNAs reveal putative neoantigen peptides for...

Response Assessment in Neuro-Oncology Criteria for Gliomas

Dr. Michael Vogelbaum co-authored a publication entitled, “RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and...

Balancing Benefits and Toxicity of Immunotherapy in Melanoma

Drs. Peter Forsyth and Muhammad Jaffer co-authored the publication entitled, “A Brain, A Heart, and the Courage: Balancing Benefit and Toxicity of...

Improving Brain Metastases Outcomes Through SRS and Targeted Therapies

Members of the Neuro-Oncology team co-authored a publication entitled, “Improving Brain Metastases Outcomes Through Therapeutic Synergy Between...

Impact of Surgical Margin and Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma

“Impact of Surgical Margin and Extent of Lymphadenectomy on Oncologic Outcomes in Plasmacytoid Urothelial Carcinoma” explores guideline...

Immunotherapy in the Treatment of Localized Genitourinary Cancers

Urologists in the Department of Genitourinary Oncology co-authored the publication, "Immunotherapy in the Treatment of Localized Genitourinary...

Dr. Fernandez SpaceOAR Hydrogel Center of Excellence Recognition

Radiation oncologist Dr. Dan Fernandez has been designated as a Center of Excellence for SpaceOAR™ Hydrogel.

Revisiting Mechanisms of Resistance to Immunotherapies in Metastatic Clear-Cell Renal-Cell Carcinoma

Urologists in the Department of Genitourinary Oncology co-authored a publication entitled “Revisiting mechanisms of resistance to immunotherapies in...

How the IPOP Service Is Shaping the Standard of Care in Infusion Centers

The IPOP provides a new way for patients to receive the chemotherapy infusions they need in the comfort of an outpatient setting.

Impacts of Socioeconomic Status and Cancer Care

Arnold Etame, a neurosurgeon and research scientist in the Department of Neuro-Oncology, discusses how socioeconomic status can impact cancer...

Testing Metformin for Oral Cancer Prevention

The objective of clinical trial MCC 21940 is to help researchers determine the historical response to metformin intervention that can stop changes in...

Meet the Experts: Q&A with Drs. Monsour and Danan

Head and Neck surgeon, Dr. Deepa Danan and endocrinologist, Dr. Elio Monsour, share their clinical interests and what they hope to bring to the...

The Use of Radiomics in Breast Imaging May Result in Improved Patient Outcomes

The use of radiomics positivity impacts imaging assessments and outcomes, especially in early-stage breast cancers.

Clinical Trials: A Guide for Primary Care Providers

In recent years, cancer clinical trials have witnessed significant advancements, offering new hope to patients and providers alike.